129 Treatment of Hypogonadism in the Solid Organ Transplant Recipient: A Case Series from a High-volume Andrology Clinic

Abstract

Solid organ transplantation (SOT) rates and successes have increased in the past 5 years. Given the chronic illness that requires a SOT, many male SOT patients are hypogonadal, with one series finding 25% of kidney transplant patients to have low testosterone1. Treatment for hypogonadism in this patient population is rarely reported in the literature, with the largest series to our knowledge including less than 20 patients. We report our experience with treatment of hypogonadism in the male SOT recipient, focusing on treatment modalities and complications of treatment – specifically the incidence of prostate cancer. Using billing data from a single practice, men who underwent a solid organ transplant and were treated for hypogonadism were identified. Retrospective chart review was then performed to identify clinical parameters, including baseline testosterone, modality of treatment, presence of polycythemia, and diagnosis of prostate cancer. Descriptive statistics, including means and standard errors, were calculated.